Latest News
Here you find the latest news revolving Sensidose.
Sensidose’s founder talks about the company’s journey (Biostock interview)
The idea for Sensidose’s treatment strategy came about already in the mid-1990s when professors Sten-Magnus Aquilonius and Christer Nyström realized that it would be possible to personalise Parkinson’s treatment with microtablets. Today, the company’s drug Flexilev...
Sensidose recruits Deputy CEO for the expansion
Pharma company Sensidose has recruited Philip Slätis as Chief Operating Officer and Deputy CEO. Slätis takes on on his role on November 1 and brings broad experience from the pharmaceutical industry. He is expected to contribute to the company’s business development...
Sensidose reinforces its management. Philip Slätis has been hired as Chief Operating Officer and Deputy CEO of Sensidose AB. Philip will take up the position on 1st November in 2022
Sollentuna 1:a September 2022 Sensidose reinforces its management. Philip Slätis has been hired as Chief Operating Officer and Deputy CEO of Sensidose AB. Philip will take up the position on 1st November in 2022. - Philips' broad experience from all parts of the...
Biostock: Continued positive sales development for Sensidose
Sensidose recently reported an increase in net sales of 21 per cent for the second quarter compared to the same period in 2021. At the same time as the company is growing, they have also made progress during the quarter in the development of the new dosing device,...
Sensidose will participate at the BioStock Investor Meeting on March 16
Sensidose will participate at the BioStock Investor Meeting on March 16. The presentation starts at 14:05. Follow the event online here: https://youtu.be/tv-ZDUn3zzI https://youtu.be/tv-ZDUn3zzI #Sensidose #BioStockSWE #investormeeting #LifeSciences
Sensidose signs an agreement with Desitin Arzneimittel GmbH for sales and marketing of Flexilev/Suades in Germany
Sensidose AB (the "Company") has entered into a service agreement with Desitin Arzneimittel GmbH ("Desitin") for the sales and marketing of Flexilev (under the trade name Suades) in Germany. Sensidose and Desitin will share the revenue from the sales. The launch is...